In univariate analysis, post-transplant hyperlipidemia (odds ratio = 3.47: 95% CI 1.092–11.030; P-Value = 0.029), PTDM (odds ratio = 4.23: 95% CI 1.480–12.128; P-Value = 0.005), and low serum adiponectin level (P = 0.045) were associated with hepatic steatosis in lean liver transplant recipients (Table 4). Here, ADIPOQ is linked to fatty liver disease.